Advertisement
Advertisement

CLYM

CLYM logo

Climb Bio, Inc. Common Stock

4.47
USD
Sponsored
-0.31
-6.55%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

4.47

0.00
+0.07%

CLYM Earnings Reports

Positive Surprise Ratio

CLYM beat 8 of 12 last estimates.

67%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Climb Bio, Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, CLYM reported earnings of -0.19 USD per share (EPS) for Q3 25, missing the estimate of -0.14 USD, resulting in a -27.01% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.56% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Climb Bio, Inc. Common Stock reported EPS of -$0.19, missing estimates by -27.01%, and revenue of $0.00, 0% as expectations.
The stock price moved up 1.56%, changed from $1.92 before the earnings release to $1.95 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Climb Bio, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement